Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuqin Lotion is a topical pharmaceutical drug formulated as a Traditional Chinese Medicine (TCM) for the treatment of vulvitis, particularly that caused by damp-heat and presenting with vulvar itching, including conditions like Trichomonas vaginitis. Its composition includes a blend of herbal ingredients such as Sophora flavescens, Artemisia argyi, Perilla frutescens, Kochia scoparia, Taraxacum mongolicum, Scutellaria baicalensis, and Zanthoxylum bungeanum. The therapeutic actions of Fuqin Lotion are rooted in TCM principles, aiming to clear heat, dry dampness, detoxify, and relieve itching, thereby exerting anti-inflammatory, antipruritic, and antimicrobial effects. It is developed by Chengdu NO1 Pharmaceutical Co., Ltd. and manufactured by companies including Chengdu NO1 Pharmaceutical Co., Ltd. and Hangzhou Wanghua Pharmaceutical Co., Ltd.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuqin Lotion.